Insider Selling: Teleflex Incorporated (NYSE:TFX) Director Sells 8,500 Shares of Stock

Share on StockTwits

Teleflex Incorporated (NYSE:TFX) Director Benson Smith sold 8,500 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $332.65, for a total value of $2,827,525.00. Following the transaction, the director now owns 85,300 shares of the company’s stock, valued at approximately $28,375,045. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Benson Smith also recently made the following trade(s):

  • On Wednesday, July 3rd, Benson Smith sold 8,500 shares of Teleflex stock. The shares were sold at an average price of $331.90, for a total value of $2,821,150.00.
  • On Wednesday, June 19th, Benson Smith sold 8,500 shares of Teleflex stock. The shares were sold at an average price of $330.75, for a total value of $2,811,375.00.
  • On Wednesday, June 5th, Benson Smith sold 8,500 shares of Teleflex stock. The shares were sold at an average price of $296.00, for a total value of $2,516,000.00.
  • On Wednesday, May 22nd, Benson Smith sold 8,500 shares of Teleflex stock. The shares were sold at an average price of $294.56, for a total value of $2,503,760.00.
  • On Wednesday, May 8th, Benson Smith sold 8,500 shares of Teleflex stock. The shares were sold at an average price of $294.52, for a total value of $2,503,420.00.

Shares of NYSE:TFX traded up $2.47 during trading on Wednesday, hitting $333.99. The company had a trading volume of 191,100 shares, compared to its average volume of 355,969. The company has a market cap of $15.46 billion, a PE ratio of 33.74, a price-to-earnings-growth ratio of 2.22 and a beta of 1.01. Teleflex Incorporated has a one year low of $226.02 and a one year high of $337.96. The stock has a fifty day moving average price of $321.20. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.41 and a current ratio of 2.27.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.07. The business had revenue of $613.60 million during the quarter, compared to analyst estimates of $608.27 million. Teleflex had a return on equity of 18.62% and a net margin of 7.50%. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period last year, the company earned $2.15 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 11.05 EPS for the current year.

Several equities analysts have weighed in on TFX shares. Wells Fargo & Co cut Dave & Buster’s Entertainment from an “outperform” rating to a “market perform” rating and set a $48.00 price target for the company. in a report on Tuesday, June 11th. Needham & Company LLC raised their price objective on CoStar Group from $500.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Morgan Stanley lowered their price objective on Neon Therapeutics from $19.00 to $13.00 and set an “overweight” rating for the company in a research note on Tuesday. Barclays raised their price objective on Zimmer Biomet from $113.00 to $117.00 and gave the company an “underweight” rating in a research note on Monday, April 15th. Finally, Raymond James reaffirmed a “market perform” rating and issued a C$43.00 price objective on shares of Snc-Lavalin Group in a research note on Wednesday, March 27th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $333.75.

Several large investors have recently bought and sold shares of the company. FMR LLC lifted its stake in shares of Teleflex by 1.0% during the 4th quarter. FMR LLC now owns 1,357,213 shares of the medical technology company’s stock worth $350,812,000 after acquiring an additional 13,908 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 18.5% during the 1st quarter. Janus Henderson Group PLC now owns 962,391 shares of the medical technology company’s stock worth $290,796,000 after acquiring an additional 150,201 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Teleflex by 3.4% during the 4th quarter. American Century Companies Inc. now owns 915,405 shares of the medical technology company’s stock worth $236,614,000 after acquiring an additional 30,368 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Teleflex by 2.1% during the 1st quarter. Marshall Wace LLP now owns 596,777 shares of the medical technology company’s stock worth $180,322,000 after acquiring an additional 12,502 shares during the last quarter. Finally, Parnassus Investments CA lifted its stake in shares of Teleflex by 2.2% during the 1st quarter. Parnassus Investments CA now owns 504,567 shares of the medical technology company’s stock worth $152,460,000 after acquiring an additional 11,033 shares during the last quarter. 91.48% of the stock is owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

See Also: Why does the United States have a lingering trade deficit?

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.